Aradigm Corp. operates as a pharmaceutical company, which focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. Its technologies include diabetes and pain management, AERx essence devices. The company was founded in 1991 and is headquartered in Hayward, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
Frequently Asked Questions
What is Market Cap of Aradigm Corporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aradigm Corporation market cap is $2.13M.
What is the 52-week high for Aradigm Corporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aradigm Corporation 52 week high is $1.95 as of September 28, 2025.
What is the 52-week low for Aradigm Corporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aradigm Corporation 52 week low is $0.06 as of September 28, 2025.
What is Aradigm Corporation stock price today?
Aradigm Corporation stock price today is $0.12.
What was Aradigm Corporation stock price yesterday?
Aradigm Corporation stock price yesterday was $0.14.
What is the PE ratio of Aradigm Corporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aradigm Corporation’s P/E ratio is None.
What is the Price-to-Book ratio of Aradigm Corporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aradigm Corporation P/B ratio is -0.0908.
What is Aradigm Corporation's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Aradigm Corporation's EBITDA is -3.19.
What is the 50-day moving average of Aradigm Corporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aradigm Corporation 50-day moving average is $0.139.